Answers are grounded in this paper and cite their sources.
Background Crohn’s disease (CD) is a chronic, relapsing-remitting inflammatory disorder of the gastrointestinal tract that may affect any segment from the mouth to the anus. Management of haemorrhoidal disease in this population remains challenging, as surgical intervention has historically been approached cautiously due to concerns regarding impaired wound healing and postoperative septic complications. Furthermore, patients with inflammatory bowel disease are frequently excluded from studies evaluating haemorrhoidal management, limiting the available evidence base. We conducted a narrative review of the literature using PubMed, Scopus, and Google Scholar, including clinical studies, reviews, and guidelines, and two reviewers screened them independently. Summary Current evidence suggests that surgical treatment of haemorrhoidal disease in patients with CD may be feasible and safe in carefully selected cases, particularly in the context of inactive disease and absence of rectal involvement. Although historical concerns regarding impaired wound healing and septic complications remain important, contemporary evidence indicates that haemorrhoidectomy is not universally contraindicated. Outcomes appear to be strongly influenced by patient selection, disease phenotype, and operative technique, with non-excisional approaches potentially associated with lower morbidity.
No takes yet. Share an insight, caveat, or question.
Grae et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: